arrow
G

Guillaume Cayla

Universite de Montpellier
H指数:46
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials

急性心肌梗死经皮冠状动脉介入治疗后服用阿司匹林1个月与12个月的比较:TARGET-FIRST和ULTIMATE-DAPT试验的个体患者数据分析

2026-08-290
OAAI
Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial

在急性冠脉综合征高风险出血患者中使用可降解聚合物西罗莫司洗脱支架或持久聚合物卓他莫司洗脱支架:BIOFLOW-DAPT随机试验

2026-08-050
PRE
Respective association with mortality of ischemic and haemorrhagic complications following percutaneous coronary intervention: insights from the FRANCE PCI registry

经皮冠状动脉介入治疗后缺血性和出血性并发症与死亡率的各自关联:法国PCI注册研究的见解

2026-08-010
OAAI
Radiation dose reference levels for the most common image-guided interventional cardiac electrophysiology and pacing procedures: a French multicentre survey

放射性剂量参考水平用于最常见的影像引导下心内电生理和起搏介入程序:一项法国多中心调查

2026-07-010
PRE
Variability of lipoprotein(a) levels in patients with acute myocardial infarction between admission, discharge, and follow-up

急性心肌梗死患者中脂蛋白(a)水平在入院、出院和随访期间的变异性

2026-01-010
PRE
Impact of P2Y12 inhibitors pretreatment on stent thrombosis in patients undergoing percutaneous coronary intervention: insight France PCI registry

P2Y12抑制剂预处理对经皮冠状动脉介入治疗患者支架血栓形成的影响:法国PCI注册研究的见解

2025-10-300
PRE
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial

β-受体阻滞剂中断对心肌梗死后血压和心率的影响:AβYSS试验

2025-05-221
PRE
Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement FRANCE 2 and FRANCE TAVI Registries

经导管主动脉瓣置换术后再干预结局的预测因素:FRANCE 2和FRANCE TAVI注册研究

2025-03-012
PRE
Gender-specific characteristics and in-hospital outcomes of active smokers with STEMI: contemporary data from the FRENCHIE cohort

女性特异性和院内结局:活动期吸烟者伴ST段抬高型心肌梗死:FRENCHIE队列的现代数据

2024-11-120
PRE
Beta-Blocker Interruption or Continuation after Myocardial Infarction
2024-10-109
PRE
PRADOC: A Multicenter Randomized Controlled Trial to Assess the Efficiency of PRADO-IC, a Nationwide Pragmatic Transition Care Management Plan for Hospitalized Patients With Heart Failure in France
2024-08-061
PRE
Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction
2024-06-012
OA